Search research articles
Contact Us
Filters
Showing results (121-130 of 128) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 128 results.
Gait & Posture
|
November 18, 2019
Lifespan data on postural balance in multiple standing positions
J Riis, F Eika, A W Blomkvist, et al.
Diabetes/Metabolism Research and Reviews
|
February 18, 2011
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy
Kim Henriksen, Inger Byrjalsen, Per Qvist, et al.
Bone
|
October 26, 2018
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial
P D Miller, G Hattersley, E Lau, et al.
Osteoarthritis and Cartilage
|
January 11, 2015
OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA
M A Karsdal, A Bihlet, I Byrjalsen, et al.
Journal of Clinical Pharmacology
|
July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials
M A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Bone
|
July 28, 2016
A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D
Kim Henriksen, Inger Byrjalsen, Jeppe R Andersen, et al.
Clinical Biochemistry
|
August 17, 2010
Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopes
D J Leeming, D V Larsen, C Zhang, et al.
Bone
|
December 14, 2012
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis
K Henriksen, J R Andersen, B J Riis, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 128) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 128 results.
Gait & Posture
|
November 18, 2019
Lifespan data on postural balance in multiple standing positions
J Riis, F Eika, A W Blomkvist, et al.
Diabetes/Metabolism Research and Reviews
|
February 18, 2011
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy
Kim Henriksen, Inger Byrjalsen, Per Qvist, et al.
Bone
|
October 26, 2018
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial
P D Miller, G Hattersley, E Lau, et al.
Osteoarthritis and Cartilage
|
January 11, 2015
OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA
M A Karsdal, A Bihlet, I Byrjalsen, et al.
Journal of Clinical Pharmacology
|
July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials
M A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Bone
|
July 28, 2016
A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D
Kim Henriksen, Inger Byrjalsen, Jeppe R Andersen, et al.
Clinical Biochemistry
|
August 17, 2010
Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopes
D J Leeming, D V Larsen, C Zhang, et al.
Bone
|
December 14, 2012
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis
K Henriksen, J R Andersen, B J Riis, et al.
Page
of 13